Bank of New York Mellon Corp lessened its stake in shares of Constellium SE (NYSE:CSTM - Free Report) by 28.0% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 337,383 shares of the industrial products company's stock after selling 131,231 shares during the quarter. Bank of New York Mellon Corp owned approximately 0.24% of Constellium worth $3,404,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also recently added to or reduced their stakes in the company. GAMMA Investing LLC lifted its stake in shares of Constellium by 2,485.6% in the 1st quarter. GAMMA Investing LLC now owns 2,689 shares of the industrial products company's stock valued at $27,000 after purchasing an additional 2,585 shares in the last quarter. Parallel Advisors LLC lifted its stake in shares of Constellium by 519.2% in the 1st quarter. Parallel Advisors LLC now owns 4,941 shares of the industrial products company's stock valued at $50,000 after purchasing an additional 4,143 shares in the last quarter. New Age Alpha Advisors LLC acquired a new position in shares of Constellium in the 4th quarter valued at about $70,000. Quadrant Capital Group LLC raised its holdings in shares of Constellium by 25.8% during the 4th quarter. Quadrant Capital Group LLC now owns 8,024 shares of the industrial products company's stock valued at $82,000 after buying an additional 1,645 shares during the period. Finally, Virtu Financial LLC purchased a new stake in shares of Constellium during the 4th quarter valued at about $106,000. 92.59% of the stock is owned by institutional investors and hedge funds.
Constellium Stock Performance
Shares of NYSE:CSTM opened at $13.62 on Friday. The company has a market cap of $1.95 billion, a P/E ratio of 29.62 and a beta of 1.69. The company has a debt-to-equity ratio of 2.49, a quick ratio of 0.53 and a current ratio of 1.24. Constellium SE has a one year low of $7.32 and a one year high of $18.15. The business's 50-day simple moving average is $13.29 and its 200 day simple moving average is $11.31.
Constellium (NYSE:CSTM - Get Free Report) last announced its earnings results on Wednesday, April 30th. The industrial products company reported $0.26 EPS for the quarter, beating the consensus estimate of $0.07 by $0.19. The business had revenue of $1.98 billion for the quarter, compared to the consensus estimate of $1.88 billion. Constellium had a return on equity of 7.74% and a net margin of 0.92%. The company's revenue was up 5.3% on a year-over-year basis. During the same period last year, the business posted $0.11 EPS. On average, sell-side analysts forecast that Constellium SE will post 1.1 earnings per share for the current fiscal year.
Constellium Profile
(
Free Report)
Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of rolled and extruded aluminum products for the packaging, aerospace, automotive, defense, and other transportation and industry end-markets. The company operates through three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Constellium, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Constellium wasn't on the list.
While Constellium currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.